| I.1 | A Needs-Based Approach to Health Technology Innovation: The Stanford Biodesign Process |
| Jonathan G Schwartz MD, Paul G Yock MD, Uday N Kumar MD, and Todd J Brinton, MD | |
| I.2 | Intellectual Property and Strategy Development |
| Neil K Nydegger Esq | |
| I.3 | Investigational and New Cardiovascular Devices: Strategy and Decision-Making for Reimbursement in the Post-Reform Era |
| John C Lewin MD, Janna Crittendon, Louis Garrison PhD and Larry McNeely | |
| I.4 | Sources of Funding for Early Stage Ventures |
| Ron King PhD MBA and MaryAnn Guerra MBA | |
| I.5 | Anesthesia and Care of the Large Animal for Survival Studies: Sheep |
| Cheryl Blaze BVSc PhD MBA | |
| I.6 | Anesthesia and Care of the Large Animal for Survival Studies: Pig |
| Cheryl Blaze BVSc PhD MBA | |
| I.7 | Echocardiography in Translational Research |
| Pierre Monney MD, Xavier Jeanrenaud MD, Hendrick Tevaearai MD EMBA and Didier Locca MD | |
| I.8 | MRI in Translational Research |
| Andrew J Ludman MD, Stéphanie M Perruchoud Fluri MD, Juan F Iglesias MD, Anthony Mathur PhD and Didier Locca MD | |
| I.9 | Biomarkers in Cardiovascular Medicine |
| Christiane Chène PhD, Sarah Longnus PhD and Hendrik Tevaearai MD EMBP | |
| I.10 | Clinical Study Design for Translational Research |
| Christopher M Mullin MS and Scott Brown PhD |
| II.1 | Regulatory Pathway for 510k, IDE, and PMA |
| Deborah G Castillo PhD, Bram Zuckerman MD and Felipe Aguel PhD | |
| II.2 | EU Regulatory Frameworks for Medicines and Medical Devices for Cardiovascular Disease |
| Peter Feldschreiber LLB and Alasdair Breckenridge MD | |
| II.3 | Product Development of Devices |
| Robert E Kohler MS | |
| II.4 | Large Animal Models for Cardiovascular Device Development |
| Yanping Cheng MD, Daniel Burkhoff MD PhD and Juan Granada MD | |
| II.5 | Translational Platform for Aortic Valve Replacement |
| Alain Cribier MD | |
| II.6 | Translational Pathway for Tissue Engineered Aortic Valves |
| Jerome Sohier PhD, Adrian H Chester BSC PhD and Sir Magdi H Yacoub MD | |
| II.7 | Translational Platform for Mitral Valve Repair and Replacement |
| David G Reuter MD PhD and Patrick M Sullivan MD | |
| II.8 | Electrophysiology: Translational Research Platforms |
| Fu Siong Ng PhD, Michael T Debney and Nicholas S Peters MD | |
| II.9 | The Translational Pathway for Mechanical Circulatory Support |
| Toshinobu Kazui MD PhD, Tia Pilikian MS, Destiny Lagrand BA, Richard G Smith MSEE CCE, Sir Magdi H Yacoub MD and Zain Khalpey MD PhD |
| IV.1 | Regulatory Considerations for Drug Development |
| Christiane Chène PhD and Hendrik T Tevaearai MD EMBA | |
| IV.2 | Translational Pathway for Drug Development |
| Hendrik T Tevaearai MD EMBA, Sarah L Longnus PhD, André Roland MSc, Florian Dick MD, Olaf Stanger MD, Didier Locca MD and Christiane Chène PhD | |
| IV.3 | Personalized Medicine and Translational Genomics |
| Robert Roberts MD |
